For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
As winter brings a rise in coughs, colds, and fevers, it’s often hard to tell if it’s just a seasonal viral, the flu, or ...
BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U ...
By leveraging advanced Polymerase Chain Reaction (PCR) technology with streamlined testing for a broad range of gastrointestinal ... These figures highlight the urgent need for rapid, accurate ...
“The rapid expansion of PCR-based testing for both infectious and genetic diseases ... are rapidly adopting PCR and ...
At-home tests of the gut's microbiome are trending, but doctors say the technology is getting ahead of medical knowledge.
The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...
The data points toward a hybrid model where quality responsibility becomes increasingly distributed. And automation is ...
According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...
From monitoring testosterone to screening for STDs or nutrient deficiencies, these tests are designed to put more control in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback